Mutant protein
Abstract
The present invention relates to an immunoglobulin-binding protein, wherein at least one asparagine residue has been mutated to an amino acid other than glutamine or aspartic acid, which mutation confers an increased chemical stability at pH-values of up to about 13-14 compared to the parental molecule. The protein can for example be derived from a protein capable of binding to other regions of the immunoglobulin molecule than the complementarity determining regions (CDR), such as protein A, and preferably the B-domain of Staphylococcal protein A. The invention also relates to a matrix for affinity separation, which comprises an immunoglobulin-binding protein as ligand coupled to a solid support, in which protein ligand at least one asparagine residue has been mutated to an amino acid other than glutamine.
Claims
exact text as granted — not AI-modified1 . In a method of preparing a separation matrix comprising at least one ligand with affinity for the Fc part of an antibody, which method comprises
(a) providing a nucleic acid sequence encoding at least one alkali-stable domain B of staphylococcal Protein A (SpA); (b) mutating said nucleic acid sequence to encode for a recombinant protein wherein at least one glycine has been replaced by an alanine; (c) expressing the protein encoded by the nucleic acid sequence resulting from (b) in a host cell; and (d) coupling the expressed protein to a support, the improvement being that the ligand(s) so prepared lack affinity for the Fab part of an antibody.
2 . The method of claim 1 , wherein in the alkali-stable domain B, the alkali-stability has been achieved by mutating at least one asparagine residue to an amino acid other than glutamine.
3 . The method of claim 1 , wherein in the alkali-stable domain B, the alkali-stability has been achieved by mutating at least one asparagine residue to an amino acid other than glutamine; and wherein glycine at position 29 of the alkali-stable domain B has been replaced by an alanine.
4 . The method of claim 1 , wherein the recombinant protein expressed in (c) is Protein Z in which the alkali-stability has been achieved by mutating at least one asparagine residue to an amino acid other than glutamine.
5 . The method of claim 1 , wherein the recombinant protein expressed in (c) is Protein Z in which the alkali-stability has been achieved by mutating at least the asparagine residue at position 23 to an amino acid other than glutamine.
6 . The method of claim 1 , wherein the nucleic acid provided encodes a multimer of two or more domains wherein at least one is Protein Z in which the alkali-stability has been achieved by mutating at least one asparagine residue to an amino acid other than glutamine.
7 . In a method of separating one or more antibodies from a liquid, which method comprises
(a) contacting liquid with a separation matrix comprising ligands immobilised to a support; (b) allowing antibodies to adsorb to said matrix by interaction with said ligands; (c) optionally washing the adsorbed antibodies; and (d) recovering antibodies by contacting said matrix with an eluent which releases the antibodies; the improvement being that said ligands comprise one or more alkali-stable domain B of staphylococcal Protein A (SpA) wherein at least one glycine has been replaced by an alanine.
8 . The method of claim 7 , wherein the recovery of antibodies is achieved by adding an eluent having a pH in the range of 3.8-3.9.
9 . The method of claim 7 , wherein at least 80% of the antibodies are recovered using an eluent having a pH in the range of 3.7-3.9.
10 . The method of claim 7 , wherein at least 90% of the antibodies are recovered using an eluent having a pH in the range of 3.7-3.9.
11 . The method of claim 7 , wherein at least 95% of the antibodies are recovered using an eluent having a pH in the range of 3.7-3.9.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.